2024 Q1 Form 10-K Financial Statement

#000149315224012382 Filed on April 01, 2024

View on sec.gov

Income Statement

Concept 2024 Q1 2023 Q4 2023
Revenue $3.849M $4.179M $12.21M
YoY Change
Cost Of Revenue $3.973M $4.252M $12.39M
YoY Change 103.69% -37.42%
Gross Profit -$124.4K -$73.13K -$178.5K
YoY Change 65.77% -108.67%
Gross Profit Margin -3.23% -1.75% -1.46%
Selling, General & Admin $2.993M $2.955M $12.17M
YoY Change 723.01% 1642.93% 2398.83%
% of Gross Profit
Research & Development $32.55K $47.08K $160.9K
YoY Change -10.39% 17.18%
% of Gross Profit
Depreciation & Amortization $33.81K $33.81K $135.3K
YoY Change 0.65% 0.65%
% of Gross Profit
Operating Expenses $3.025M $3.003M $12.33M
YoY Change 731.96% 1670.7% 2431.86%
Operating Profit -$3.150M -$3.076M -$12.51M
YoY Change 766.15% 2468.5%
Interest Expense $79.31K -$79.52K $103.6K
YoY Change -131.53% -102.15% -98.65%
% of Operating Profit
Other Income/Expense, Net -$79.25K $70.00 -$103.5K
YoY Change -3450066.67%
Pretax Income -$3.229M -$3.155M -$12.61M
YoY Change 424.84% -189.3% -275.78%
Income Tax $2.460K $2.464K
% Of Pretax Income
Net Earnings -$3.229M -$3.204M -$12.62M
YoY Change 424.84% -190.69% -275.81%
Net Earnings / Revenue -83.9% -76.67% -103.29%
Basic Earnings Per Share -$0.28 -$2.00
Diluted Earnings Per Share -$0.28 -$0.51 -$2.00
COMMON SHARES
Basic Shares Outstanding 12.21M shares 9.015M shares 6.327M shares
Diluted Shares Outstanding 11.44M shares 6.327M shares

Balance Sheet

Concept 2024 Q1 2023 Q4 2023
SHORT-TERM ASSETS
Cash & Short-Term Investments $595.6K $2.101M $2.101M
YoY Change -95.43% -83.9% 892.13%
Cash & Equivalents $595.6K $2.101M $2.101M
Short-Term Investments
Other Short-Term Assets $104.7K $190.1K $990.1K
YoY Change -99.19% 5194.46% 27478.55%
Inventory
Prepaid Expenses
Receivables $163.0K $96.54K $96.54K
Other Receivables $1.500M $0.00 $0.00
Total Short-Term Assets $3.163M $3.187M $3.187M
YoY Change -75.78% 1380.26% 1380.26%
LONG-TERM ASSETS
Property, Plant & Equipment $6.967K $7.604K $1.580M
YoY Change 30.79%
Goodwill
YoY Change
Intangibles $53.58K $73.83K
YoY Change -52.37%
Long-Term Investments $208.4K $208.4K $208.4K
YoY Change
Other Assets $689.8K $689.8K $689.8K
YoY Change -94.63% -94.63%
Total Long-Term Assets $2.402M $2.552M $2.552M
YoY Change -80051400.0% -80.12% -80.12%
TOTAL ASSETS
Total Short-Term Assets $3.163M $3.187M $3.187M
Total Long-Term Assets $2.402M $2.552M $2.552M
Total Assets $5.565M $5.739M $5.739M
YoY Change -57.4% -56.02% -56.02%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.386M $1.657M $1.657M
YoY Change 582.07%
Accrued Expenses $2.444M $2.417M $2.927M
YoY Change 618.5% 2366.92% 2887.5%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $588.0K $588.0K
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $5.740M $6.952M $6.952M
YoY Change 1587.35% 6726.16% 6726.3%
LONG-TERM LIABILITIES
Long-Term Debt $1.702M $1.702M $1.702M
YoY Change 196.0% 196.0% 196.0%
Other Long-Term Liabilities $891.4K $1.021M $1.021M
YoY Change -81.37% -76.76% -76.76%
Total Long-Term Liabilities $2.593M $2.723M $2.723M
YoY Change -51.61% -45.2% -45.2%
TOTAL LIABILITIES
Total Short-Term Liabilities $5.740M $6.952M $6.952M
Total Long-Term Liabilities $2.593M $2.723M $2.723M
Total Liabilities $8.333M $9.675M $9.675M
YoY Change 46.21% 90.77% 90.77%
SHAREHOLDERS EQUITY
Retained Earnings -$42.50M -$39.27M
YoY Change 657.85% 708.62%
Common Stock $1.255K $975.00
YoY Change 119.1%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$2.768M -$3.936M -$3.936M
YoY Change
Total Liabilities & Shareholders Equity $5.565M $5.739M $5.739M
YoY Change -57.4% -56.02% -56.02%

Cashflow Statement

Concept 2024 Q1 2023 Q4 2023
OPERATING ACTIVITIES
Net Income -$3.229M -$3.204M -$12.62M
YoY Change 424.84% -190.69% -275.81%
Depreciation, Depletion And Amortization $33.81K $33.81K $135.3K
YoY Change 0.65% 0.65%
Cash From Operating Activities -$2.521M -$1.039M -$3.783M
YoY Change 1634.56% 1444.51% 839.58%
INVESTING ACTIVITIES
Capital Expenditures $21.46K $4.339K
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 -$135.1K
YoY Change -100.0% -100.13%
Cash From Investing Activities -$12.92K -$21.47K -$191.0K
YoY Change -86.2% -100.02% -100.18%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $2.829M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $1.029M 2.257M $4.548M
YoY Change -10.68% -102.15% -104.34%
NET CHANGE
Cash From Operating Activities -$2.521M -1.039M -$3.783M
Cash From Investing Activities -$12.92K -21.47K -$191.0K
Cash From Financing Activities $1.029M 2.257M $4.548M
Net Change In Cash -$1.505M 1.197M $573.2K
YoY Change 935.59% -1879.11% -242.34%
FREE CASH FLOW
Cash From Operating Activities -$2.521M -$1.039M -$3.783M
Capital Expenditures $21.46K $4.339K
Free Cash Flow -$2.521M -$1.060M -$3.788M
YoY Change 1584.28% 840.66%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
usd
CY2022Q4 JTAI Prepaid Offering Costs And Accounts Payable
PrepaidOfferingCostsAndAccountsPayable
usd
CY2022Q4 us-gaap Investments And Other Noncurrent Assets
InvestmentsAndOtherNoncurrentAssets
usd
CY2022Q4 us-gaap Preferred Stock Redemption Amount
PreferredStockRedemptionAmount
usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2022 us-gaap Interest Expense
InterestExpense
usd
CY2022 us-gaap Other Preferred Stock Dividends And Adjustments
OtherPreferredStockDividendsAndAdjustments
usd
CY2022 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
usd
CY2022 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
usd
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
usd
CY2022 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
usd
CY2022 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
usd
CY2023 JTAI Return Of Aircraft Deposit
ReturnOfAircraftDeposit
usd
CY2023 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
usd
CY2023 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
usd
CY2022 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
usd
CY2022 JTAI Proceeds From Related Party Notes Payable
ProceedsFromRelatedPartyNotesPayable
usd
CY2023 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
usd
CY2022 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
usd
CY2023 us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
usd
CY2022 JTAI Proceeds From Business Combination
ProceedsFromBusinessCombination
usd
CY2023 us-gaap Interest Paid Net
InterestPaidNet
usd
CY2022 us-gaap Interest Paid Net
InterestPaidNet
usd
CY2023 JTAI Operating Lease Rightofuse Assets And Liabilities
OperatingLeaseRightofuseAssetsAndLiabilities
usd
CY2022 JTAI Increase In Accounts Payable Due To Business Combination
IncreaseInAccountsPayableDueToBusinessCombination
usd
CY2022 JTAI Increase In Redeemable Preferred Stock Due To Business Combination
IncreaseInRedeemablePreferredStockDueToBusinessCombination
usd
CY2022 JTAI Prepaid Offering Costs
PrepaidOfferingCosts
usd
CY2022 JTAI Discounts Issued With Notes Payable
DiscountsIssuedWithNotesPayable
usd
CY2023Q4 us-gaap Property Plant And Equipment Useful Life
PropertyPlantAndEquipmentUsefulLife
P3Y
CY2022Q4 us-gaap Property Plant And Equipment Useful Life
PropertyPlantAndEquipmentUsefulLife
P3Y
CY2022 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
shares
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
shares
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
CY2023 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
shares
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2023Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
usd
CY2022Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
usd
CY2023 dei Document Type
DocumentType
10-K
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Document Period End Date
DocumentPeriodEndDate
2023-12-31
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023 dei Entity Small Business
EntitySmallBusiness
true
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2023 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2023 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2023 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2023 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Public Float
EntityPublicFloat
12902168 usd
CY2024Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
12205144 shares
CY2023 dei Auditor Firm
AuditorFirmId
34
CY2023 dei Auditor Name
AuditorName
HACKER, JOHNSON & SMITH PA
CY2023 dei Auditor Location
AuditorLocation
Tampa, Florida
CY2022 dei Auditor Name
AuditorName
BF Borgers CPA
CY2022 dei Auditor Firm
AuditorFirmId
5041
CY2022 dei Auditor Location
AuditorLocation
Lakewood, CO
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2100543 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1527391 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
96539 usd
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
190071 usd
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
357861 usd
CY2023Q4 JTAI Prepaid Offering Costs And Accounts Payable
PrepaidOfferingCostsAndAccountsPayable
800000 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
3187153 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
1885252 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7604 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5814 usd
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
73831 usd
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
155009 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1572489 usd
CY2022 us-gaap Cost Of Revenue
CostOfRevenue
19803739 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2081568 usd
CY2023Q4 us-gaap Investments And Other Noncurrent Assets
InvestmentsAndOtherNoncurrentAssets
100000 usd
CY2023Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
798111 usd
CY2022Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
762976 usd
CY2023Q4 us-gaap Assets
Assets
5739188 usd
CY2022Q4 us-gaap Assets
Assets
4890619 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1656965 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
242933 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2417115 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
951689 usd
CY2023Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1779794 usd
CY2022Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
933361 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
510034 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
494979 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
6951897 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2622962 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1021330 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1531364 usd
CY2023Q4 us-gaap Preferred Stock Redemption Amount
PreferredStockRedemptionAmount
1702000 usd
CY2023Q4 us-gaap Liabilities
Liabilities
9675227 usd
CY2022Q4 us-gaap Liabilities
Liabilities
4154326 usd
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
4000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
0 shares
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
1702 shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
1702 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
55000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
55000000 shares
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
9754364 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
9754364 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4454665 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4454665 shares
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
975 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
445 usd
CY2023Q4 us-gaap Common Stock Share Subscribed But Unissued Subscriptions Receivable
CommonStockShareSubscribedButUnissuedSubscriptionsReceivable
6724 usd
CY2022Q4 us-gaap Common Stock Share Subscribed But Unissued Subscriptions Receivable
CommonStockShareSubscribedButUnissuedSubscriptionsReceivable
15544 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
35342098 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
27407372 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-39272388 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-26655980 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-3936039 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
736293 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
5739188 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4890619 usd
CY2023 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
12214556 usd
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
21862728 usd
CY2023 us-gaap Cost Of Revenue
CostOfRevenue
12393089 usd
CY2023 us-gaap Gross Profit
GrossProfit
-178533 usd
CY2022 us-gaap Gross Profit
GrossProfit
2058989 usd
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
6645891 usd
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
6492653 usd
CY2023 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
11597173 usd
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
9230789 usd
CY2023 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
573881 usd
CY2022 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
426728 usd
CY2023 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
160858 usd
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
137278 usd
CY2023 us-gaap Operating Expenses
OperatingExpenses
12331912 usd
CY2022 us-gaap Operating Expenses
OperatingExpenses
9794795 usd
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
-12510445 usd
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-7735806 usd
CY2023 us-gaap Interest Expense
InterestExpense
103615 usd
CY2023 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
116 usd
CY2022 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
3 usd
CY2023 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-103499 usd
CY2022 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
3 usd
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-12613944 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-7735803 usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2464 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2400 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-12616408 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-7738203 usd
CY2023 us-gaap Other Preferred Stock Dividends And Adjustments
OtherPreferredStockDividendsAndAdjustments
46587 usd
CY2023 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-12662995 usd
CY2022 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-7738203 usd
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6326806 shares
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6326806 shares
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4409670 shares
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4409670 shares
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.00
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.00
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.75
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.75
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
897469 usd
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
6492653 usd
CY2022 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
2904160 usd
CY2022 JTAI Stock Issued During Period Value Receipt Of Subscription Receivable
StockIssuedDuringPeriodValueReceiptOfSubscriptionReceivable
96600 usd
CY2022 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
-1691386 usd
CY2022 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
-225000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-7738203 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
736293 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
736293 usd
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
6645891 usd
CY2023 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1512260 usd
CY2023 JTAI Stock Issued During Period Value Receipt Of Subscription Receivable
StockIssuedDuringPeriodValueReceiptOfSubscriptionReceivable
95190 usd
CY2023 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
-437665 usd
CY2023 JTAI Stock Issued During Period Value Recapitalization
StockIssuedDuringPeriodValueRecapitalization
-2128545 usd
CY2023 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1035000 usd
CY2023 us-gaap Stock Issued During Period Value Purchase Of Assets
StockIssuedDuringPeriodValuePurchaseOfAssets
1221945 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-12616408 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-3936039 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-3936039 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-12616408 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-7738203 usd
CY2023 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
135251 usd
CY2022 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
134383 usd
CY2023 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
87989 usd
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
6645891 usd
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
6492653 usd
CY2023 us-gaap Operating Lease Cost
OperatingLeaseCost
509079 usd
CY2022 us-gaap Operating Lease Cost
OperatingLeaseCost
494468 usd
CY2023 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
96539 usd
CY2023 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-167790 usd
CY2022 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
278313 usd
CY2023 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
366594 usd
CY2022 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-53268 usd
CY2023 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
665426 usd
CY2022 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
835576 usd
CY2023 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
846433 usd
CY2022 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
497030 usd
CY2023 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-494979 usd
CY2022 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-480368 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3783473 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-96042 usd
CY2023 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4339 usd
CY2023 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
51524 usd
CY2023 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
100000 usd
CY2022 JTAI Return Of Aircraft Deposit
ReturnOfAircraftDeposit
1093600 usd
CY2023 us-gaap Payments For Other Deposits
PaymentsForOtherDeposits
35135 usd
CY2022 us-gaap Payments For Other Deposits
PaymentsForOtherDeposits
803112 usd
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-190998 usd
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
290488 usd
CY2022 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
42000 usd
CY2022 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
242196 usd
CY2023 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
275000 usd
CY2023 JTAI Proceeds From Related Party Notes Payable
ProceedsFromRelatedPartyNotesPayable
225000 usd
CY2022 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
194727 usd
CY2023 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
437665 usd
CY2022 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
1691386 usd
CY2023 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
1035000 usd
CY2022 us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
-225000 usd
CY2023 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
2829395 usd
CY2022 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
3000760 usd
CY2023 JTAI Proceeds From Business Combination
ProceedsFromBusinessCombination
620893 usd
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
4547623 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
689451 usd
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
573152 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
883897 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1527391 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
643494 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2100543 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1527391 usd
CY2023 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
2464 usd
CY2022 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
2400 usd
CY2023 JTAI Subscription Receivable From Sale Of Nonvoting Common Stock
SubscriptionReceivableFromSaleOfNonvotingCommonStock
86370 usd
CY2022 JTAI Subscription Receivable From Sale Of Nonvoting Common Stock
SubscriptionReceivableFromSaleOfNonvotingCommonStock
15544 usd
CY2022 JTAI Operating Lease Rightofuse Assets And Liabilities
OperatingLeaseRightofuseAssetsAndLiabilities
2506711 usd
CY2023 JTAI Increase In Accounts Payable Due To Business Combination
IncreaseInAccountsPayableDueToBusinessCombination
1047438 usd
CY2023 JTAI Increase In Redeemable Preferred Stock Due To Business Combination
IncreaseInRedeemablePreferredStockDueToBusinessCombination
1702000 usd
CY2023 JTAI Prepaid Offering Costs
PrepaidOfferingCosts
800000 usd
CY2023 JTAI Discounts Issued With Notes Payable
DiscountsIssuedWithNotesPayable
168750 usd
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023 us-gaap Capitalized Computer Software Additions
CapitalizedComputerSoftwareAdditions
398000 usd
CY2023 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_847_eus-gaap--UseOfEstimates_zSfPICVXCsO8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Use of Estimates</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of the consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statement and the reported amounts of expenses during the reporting period. Making estimates requires management to exercise significant judgement. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q4 us-gaap Restricted Cash
RestrictedCash
500000 usd
CY2022Q4 us-gaap Restricted Cash
RestrictedCash
500000 usd
CY2023 us-gaap Property Plant And Equipment Impairment
PropertyPlantAndEquipmentImpairment
<p id="xdx_845_eus-gaap--PropertyPlantAndEquipmentImpairment_zLDhiTuI7H36" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Property and Equipment</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property and equipment are recorded at cost, less accumulated depreciation. Expenditures for major additions and improvements are capitalized and minor replacements, maintenance, and repairs are charged to expense as incurred. When property and equipment are retired or otherwise disposed of, the cost and accumulated depreciation are removed from the accounts and any resulting gain or loss is included in the results of operations for the respective period. Depreciation is provided over the estimated useful lives of the related assets using the straight-line method for financial statement purposes. As of December 31, 2023 and 2022, property and equipment consisted entirely of equipment which is being depreciated over a <span id="xdx_909_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dxL_c20231231_z57clj1dCAOg" title="Useful lives::XDX::P3Y"><span id="xdx_90B_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dxL_c20221231_zkQndsXdNlw" title="Useful lives::XDX::P3Y"><span style="-sec-ix-hidden: xdx2ixbrl0584"><span style="-sec-ix-hidden: xdx2ixbrl0586">three</span></span></span></span>-year period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022Q4 us-gaap Other Assets
OtherAssets
762976 usd
CY2022 us-gaap Capitalized Computer Software Additions
CapitalizedComputerSoftwareAdditions
398000 usd
CY2023 us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
132702 usd
CY2022 us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
132702 usd
CY2023Q4 us-gaap Capitalized Computer Software Accumulated Amortization
CapitalizedComputerSoftwareAccumulatedAmortization
398101 usd
CY2023Q4 us-gaap Investments And Other Noncurrent Assets
InvestmentsAndOtherNoncurrentAssets
100000 usd
CY2023 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
12214556 usd
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
21862728 usd
CY2023 us-gaap Advertising Expense
AdvertisingExpense
573881 usd
CY2022 us-gaap Advertising Expense
AdvertisingExpense
426728 usd
CY2023 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_840_eus-gaap--ConcentrationRiskCreditRisk_zn2QTBghB767" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Concentration of Credit Risk</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company maintains its cash with several major financial institutions located in the United States of America which it believes to be creditworthy. Balances are insured by the Federal Deposit Insurance Corporation up to $<span id="xdx_904_eus-gaap--CashFDICInsuredAmount_iI_c20231231_zeU0CBXuryS3" title="Cash FDIC insured amount">250,000</span>. At times, the Company may maintain balances in excess of the federally insured limits.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q4 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0 usd
CY2023Q4 us-gaap Deposits Assets Current
DepositsAssetsCurrent
108361 usd
CY2022Q4 us-gaap Deposits Assets Current
DepositsAssetsCurrent
73226 usd
CY2023Q4 JTAI Lease Maintenance Reserve
LeaseMaintenanceReserve
689750 usd
CY2022Q4 JTAI Lease Maintenance Reserve
LeaseMaintenanceReserve
689750 usd
CY2023Q4 us-gaap Other Assets
OtherAssets
798111 usd
CY2023Q3 us-gaap Proceeds From Debt Net Of Issuance Costs
ProceedsFromDebtNetOfIssuanceCosts
500000 usd
CY2023Q3 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
112500 usd
CY2023Q3 us-gaap Debt Instrument Interest Rate Effective Percentage
DebtInstrumentInterestRateEffectivePercentage
0.05 pure
CY2023Q3 us-gaap Debt Instrument Maturity Date
DebtInstrumentMaturityDate
2024-03-11
CY2023Q3 us-gaap Debt Instrument Redemption Description
DebtInstrumentRedemptionDescription
The Company is required to redeem the notes with one hundred percent (100%) of the proceeds of any equity or debt financing, on a pro rata basis, at a redemption premium of one hundred and ten percent (110%) of the principal amount of the notes. The Company anticipates redeeming the notes in full with proceeds expected to be received over the next several months from existing financing arrangements.
CY2023Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
181250 usd
CY2023 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
90625 usd
CY2023 us-gaap Interest Expense Debt
InterestExpenseDebt
103615 usd
CY2023Q3 us-gaap Debt Conversion Description
DebtConversionDescription
In an event of default, the outstanding principal of the notes shall increase by one hundred and twenty percent (120%), and investors may convert the notes into common stock of the Company at the lower of (a) the Fixed Conversion Price or (b) the lowest daily volume-weighted average price reported by Bloomberg (“VWAP”) of the Common Stock during the ten (10) business days before the conversion date. If the daily VWAP of the common stock is below $1.00 for ten (10) consecutive trading days, the Conversion Price shall be 95% of the lowest daily VWAP ten (10) days before conversion date.
CY2023 us-gaap Operating Lease Expense
OperatingLeaseExpense
1192184 usd
CY2022 us-gaap Operating Lease Expense
OperatingLeaseExpense
863824 usd
CY2023Q4 JTAI Operating Lease Right Of Use Of Asset
OperatingLeaseRightOfUseOfAsset
2576036 usd
CY2022Q4 JTAI Operating Lease Right Of Use Of Asset
OperatingLeaseRightOfUseOfAsset
2576036 usd
CY2023Q4 JTAI Operating Lease Right Of Use Asset Accumulated Amortization
OperatingLeaseRightOfUseAssetAccumulatedAmortization
1003547 usd
CY2022Q4 JTAI Operating Lease Right Of Use Asset Accumulated Amortization
OperatingLeaseRightOfUseAssetAccumulatedAmortization
494468 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1572489 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2081568 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
510034 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
494979 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1021330 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1531364 usd
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
1531364 usd
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
2026343 usd
CY2023Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y
CY2023Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.03 pure
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
549000 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
549000 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
503250 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
1601250 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
69886 usd
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
1531364 usd
CY2023Q3 us-gaap Prepayment Fees On Advances Net
PrepaymentFeesOnAdvancesNet
625000 usd
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
59000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
1702 shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
1702 shares
CY2023Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
11.50
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2932392 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.09
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y11M4D
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
284016 shares
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
10.42
CY2022 JTAI Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term Granted
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted
P10Y
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3216408 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.48
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y21D
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
458080 shares
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
3.91
CY2023 JTAI Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term Granted
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted
P10Y
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
15473 shares
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
10.42
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3659015 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.19
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y4M24D
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
2943807 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
7.64
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P7Y1M6D
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0355 pure
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0455 pure
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0143 pure
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0410 pure
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.90 pure
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.80 pure
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2023Q4 us-gaap Share Price
SharePrice
2.58
CY2022Q4 us-gaap Share Price
SharePrice
17.47
CY2023 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
6645891 usd
CY2022 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
6942653 usd
CY2023Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
4690000 usd
CY2023Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
25975001 shares
CY2022Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
933361 usd
CY2023 us-gaap Contract With Customer Liability Change In Timeframe Performance Obligation Satisfied Revenue Recognized
ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized
3695476 usd
CY2023 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
-933361 usd
CY2023 JTAI Revenue From Current Period Sales
RevenueFromCurrentPeriodSales
-1915682 usd
CY2023Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1779794 usd
CY2023 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2023 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.000 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.000 pure
CY2023 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
-0.111 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
-0.176 pure
CY2023 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.001 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.000 pure
CY2023 JTAI Effective Income Tax Rate Reconciliation Temporary Differences
EffectiveIncomeTaxRateReconciliationTemporaryDifferences
-0.013 pure
CY2022 JTAI Effective Income Tax Rate Reconciliation Temporary Differences
EffectiveIncomeTaxRateReconciliationTemporaryDifferences
0.004 pure
CY2023 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.085 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.038 pure
CY2023 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.000 pure
CY2022 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.000 pure
CY2023Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
2529000 usd
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
1472000 usd
CY2023Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
2529000 usd
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
1472000 usd
CY2023 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
1087000 usd
CY2023Q4 us-gaap Operating Loss Carryforwards Valuation Allowance
OperatingLossCarryforwardsValuationAllowance
5100000 usd
CY2023Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
12100000 usd

Files In Submission

Name View Source Status
0001493152-24-012382-index-headers.html Edgar Link pending
0001493152-24-012382-index.html Edgar Link pending
0001493152-24-012382.txt Edgar Link pending
0001493152-24-012382-xbrl.zip Edgar Link pending
ex10-30.htm Edgar Link pending
ex10-31.htm Edgar Link pending
ex10-32.htm Edgar Link pending
ex23-1.htm Edgar Link pending
ex3-5.htm Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
ex4-5.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-k.htm Edgar Link pending
jtai-20231231.xsd Edgar Link pending
MetaLinks.json Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
jtai-20231231_cal.xml Edgar Link unprocessable
jtai-20231231_def.xml Edgar Link unprocessable
jtai-20231231_lab.xml Edgar Link unprocessable
jtai-20231231_pre.xml Edgar Link unprocessable
form10-k_htm.xml Edgar Link completed
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending